Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP - Related Studies

Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP

This study has been completed.

Study NCT00220727. Last updated on March 31, 2008. Information provided by Talecris Biotherapeutics

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Additional conditions recognized in this trial
		Purpura
		Purpura, Thrombocytopenic
		Purpura, Thrombocytopenic, Idiopathic

2	More general conditions related to this trial
		Autoimmune Diseases
		Blood Coagulation Disorders
		Blood Platelet Disorders
		Hematologic Diseases
		Hemorrhagic Disorders
		Immune System Diseases
		Signs and Symptoms
		Skin Manifestations
		Thrombocytopenia

3	Additional drug interventions recognized in this trial
		Immunoglobulins
		Immunoglobulins, Intravenous
		Rho(D) Immune Globulin

4	More general drug interventions related to this trial
		Immunologic Factors
		Pharmacologic Actions
		Physiological Effects of Drugs

5	Sponsors listed in this trial
		Talecris Biotherapeutics